Co announces Exelon Patch has received its first worldwide approval in the U.S. as a way to deliver an effective medicine for mild to moderate Alzheimer's disease patients through a skin patch ...

In a study aimed at finding answers for those with advanced Alzheimer’s disease, researchers at Saint Louis University are testing a new, higher dose of the Exelon (rivastigmine) patch to learn ...